SCHEMBL12135533

SCHEMBL12135533

CC(C)Oc1cccc(-c2nc(N)nc(N)c2C#Cc2cccnc2)c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.41
▸ ADORA1 P30542 3/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ RXFP1 Q9HBX9 3/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ GLA P06280 2/20 0.41
▸ DHFR P00374 7/20 0.40
▸ MAPT P10636 2/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ GABRA1 P14867 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ GABRA3 P34903 1/20 0.38
▸ PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12135488 0.89 ADORA2A (0.54) ADORA2AADORA1ADORA2BKDM4ERXFP1
SCHEMBL12135612 0.84 ADORA1 (0.47) ADORA2AADORA1ADORA2BKDM4ERXFP1
SCHEMBL13495048 0.82 MEN1 (0.48) ADORA2AADORA1ADORA2BKDM4EGLA
SCHEMBL12135303 0.81 ADORA2A (0.53) ADORA2AADORA1ADORA2BKDM4ERXFP1
SCHEMBL12137691 0.81 MAP4K4 (0.45) ADORA2AADORA1ADORA2BKDM4ERXFP1
SCHEMBL12135555 0.81 ADORA2A (0.58) ADORA2AADORA1ADORA2BKDM4EGLA
SCHEMBL12135492 0.80 DHFR (0.47) ADORA2AADORA1KDM4EGLADHFR
SCHEMBL12135513 0.80 ADORA1 (0.59) ADORA2AADORA1ADORA2BKDM4ERXFP1
SCHEMBL12135505 0.80 DHFR (0.48) ADORA2AADORA1ADORA2BKDM4ERXFP1
SCHEMBL12135541 0.78 ADORA1 (0.52) ADORA2AADORA1ADORA2BKDM4ERXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323992-B1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INT (DE) 2016-07-20 — — EP disclosed
US-8916548-B2 5-alkynyl-pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 — — US disclosed
US-8916548-B2 5-alkynyl-pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 — — US disclosed
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-17 — — US disclosed
WO-2010012740-A1 5-ALKYNYL-PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-02-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281838-A1 5-ALKYNYL-PYRIMIDINES MKI67, CCNA1, CCNT1 ADORA2A 314/4885ADORA1 87/4885ADORA2B 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback